Program in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan.
Nat Rev Clin Oncol. 2021 Apr;18(4):230-243. doi: 10.1038/s41571-020-00445-1. Epub 2020 Nov 20.
The incidence of early-onset colorectal cancer (CRC), which occurs in individuals <50 years of age, has been increasing worldwide and particularly in high-income countries. The reasons for this increase remain unknown but plausible hypotheses include greater exposure to potential risk factors, such as a Western-style diet, obesity, physical inactivity and antibiotic use, especially during the early prenatal to adolescent periods of life. These exposures can not only cause genetic and epigenetic alterations in colorectal epithelial cells but also affect the gut microbiota and host immunity. Early-onset CRCs have differential clinical, pathological and molecular features compared with later-onset CRCs. Certain existing resources can be utilized to elucidate the aetiology of early-onset CRC and inform the development of effective prevention, early detection and therapeutic strategies; however, additional life-course cohort studies spanning childhood and young adulthood, integrated with prospective biospecimen collections, omics biomarker analyses and a molecular pathological epidemiology approach, are needed to better understand and manage this disease entity. In this Perspective, we summarize our current understanding of early-onset CRC and discuss how we should strategize future research to improve its prevention and clinical management.
早发性结直肠癌(CRC)是指发生在 50 岁以下人群的癌症,其发病率在全球范围内不断上升,在高收入国家尤其如此。目前尚不清楚导致这种发病率上升的原因,但有一些合理的假说,包括更多地接触潜在的危险因素,如西式饮食、肥胖、身体活动不足和抗生素使用,尤其是在生命的早期产前到青少年时期。这些暴露不仅会导致结直肠上皮细胞的遗传和表观遗传改变,还会影响肠道微生物群和宿主免疫。与晚发性 CRC 相比,早发性 CRC 具有不同的临床、病理和分子特征。某些现有的资源可用于阐明早发性 CRC 的病因,并为制定有效的预防、早期发现和治疗策略提供信息;然而,还需要开展跨越儿童和青年期的全生命周期队列研究,结合前瞻性生物样本采集、组学生物标志物分析和分子病理流行病学方法,以更好地理解和管理这种疾病实体。在本观点中,我们总结了我们目前对早发性 CRC 的认识,并讨论了我们应该如何制定未来的研究策略,以改善其预防和临床管理。